Search references for EMRACLIDINE. Phrases containing EMRACLIDINE
See searches and references containing EMRACLIDINE!EMRACLIDINE
Chemical compound
Emraclidine (developmental code names CVL-231, PF-06852231) is an investigational antipsychotic for the treatment of both schizophrenia and Alzheimer's
Emraclidine
American biotechnology company
treatments at varying stages of development include: Tavapadon (Parkinson's) Emraclidine (Schizophrenia, Alzheimer's) Darigabat (Epilepsy) CVL-871 (Dementia,
Cerevel_Therapeutics
Antipsychotic drug
behind xanomeline/trospium (KarXT) (Karuna Therapeutics) with 8.4 and emraclidine (Cerevel Therapeutics) with 12.7, both of which were in clinical trials
Direclidine
Experimental muscarinic drug
seem to have been disclosed. List of investigational antipsychotics Emraclidine NBI-1117568 NS-136 Xanomeline/trospium (KarXT) "ML 007". AdisInsight
ML-007
American biopharmaceutical company
(developed by Karuna Therapeutics) and the 12.7-point improvement seen with Emraclidine (developed by Cerevel Therapeutics), both of which were also in clinical
Neurocrine_Biosciences
Investigational antipsychotics
receptor antagonist, and other actions – schizoaffective disorder [21] Emraclidine (CVL-231; PF-06852231) – muscarinic acetylcholine M4 receptor positive
List of investigational antipsychotics
List_of_investigational_antipsychotics
Protein-coding gene
GXV-813 (EX-A8078) ML-007 Oxotremorine Xanomeline (+trospium) Clozapine Emraclidine (CVL-231, PF-06852231) LY-2033298 NS-136 SUVN-L3307032 VU-0152100 (ML-108)
Muscarinic acetylcholine receptor M4
Muscarinic_acetylcholine_receptor_M4
Experimental muscarinic drug
seem to have been disclosed. List of investigational antipsychotics Emraclidine NBI-1117568 Xanomeline "NS 136". AdisInsight. Springer Nature Switzerland
NS-136
EMRACLIDINE
EMRACLIDINE
EMRACLIDINE
EMRACLIDINE
EMRACLIDINE
EMRACLIDINE
EMRACLIDINE
EMRACLIDINE
EMRACLIDINE